Aptose Biosciences (APTO) Reports Q1 Loss of $0.23

Aptose Biosciences (NASDAQ: APTO) reported Q1 EPS of ($0.23), versus ($0.19) reported last year. Revenue for the quarter came in at $3.14 million, versus $1.74 million reported last year.

For earnings history and earnings-related data on Aptose Biosciences (APTO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79